Metformin Dosage: Starting Doses, Titration, and Maximum Limits Explained

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Standard adult starting dose for immediate-release (IR) metformin is 500 mg once or twice daily, taken with food.
• Most adults titrate to 1,500 to 2,000 mg per day in two or three divided doses, which is the typical effective range for type 2 diabetes.
• The FDA-approved maximum daily dose is 2,550 mg for IR metformin and 2,000 mg for extended-release (ER) metformin in adults.
• Dose increases of 500 mg per week reduce GI side effects compared with faster titration.
• Patients with reduced kidney function (eGFR 30 to 45 mL/min/1.73 m²) need a lower dose; metformin is contraindicated below eGFR 30.

Direct answer (40-60 words)

Adult metformin dosing starts at 500 mg once or twice daily with meals. Patients titrate up by 500 mg per week to a target of 1,500 to 2,000 mg per day. The FDA-approved maximum is 2,550 mg per day for immediate-release tablets and 2,000 mg per day for extended-release tablets. Kidney function determines maximum allowable dose.

Table of contents

1. Standard adult starting dose
2. Titration schedule for immediate-release metformin
3. Extended-release (ER) metformin dosing
4. Maximum daily dose: IR vs ER
5. Dosing in pediatric patients
6. Kidney function and dose adjustment
7. Metformin dosing in PCOS, prediabetes, and off-label use
8. Metformin alongside GLP-1 medications
9. Missed doses and overdose
10. FAQ
11. Sources
12. Footer disclaimers

Standard adult starting dose

The standard starting dose for immediate-release metformin in adults is 500 mg taken once or twice daily with meals. Some prescribers begin at 850 mg once daily for patients who tolerate larger pills well, but 500 mg twice daily is the more common starting point because it splits the GI burden across two meals.

Metformin is always taken with food. Empty-stomach dosing increases nausea, bloating, and diarrhea, the three side effects that lead most patients who quit metformin to quit it. The American Diabetes Association's 2024 Standards of Care recommends starting low and going slow specifically because the GI tolerability of metformin improves dramatically with a gradual titration (ADA, Diabetes Care 2024).

Take metformin with the largest meal of the day if you start at 500 mg once daily. If you start at 500 mg twice daily, take one dose with breakfast and one with dinner. Do not crush or split tablets unless your prescriber tells you to. Crushing the immediate-release form is generally fine; crushing extended-release tablets defeats the purpose of the formulation and causes a dose dump.

Titration schedule for immediate-release metformin

Most patients move through a stepwise titration over three to four weeks. The schedule below is the one used in the original UK Prospective Diabetes Study (UKPDS) protocol and is still the foundation for most modern dosing guidelines (UKPDS Group, Lancet 1998).

If GI side effects appear at any step, stay at the current dose for an extra week before going up. Some patients sit at 1,000 mg per day permanently because the difference in glucose control between 1,000 mg and 2,000 mg is smaller than most assume. The dose-response curve flattens above 1,500 mg.

For patients moving from 1,500 mg to 2,000 mg, the smart approach is to take 1,000 mg with breakfast and 1,000 mg with dinner rather than splitting awkwardly into a 500 / 1,000 / 500 mg three-times-daily pattern. Twice-daily dosing improves adherence without losing efficacy.

Extended-release (ER) metformin dosing

Extended-release metformin (often labeled ER, XR, or SR depending on the brand) is taken once daily with the evening meal. The starting dose is 500 mg once daily, titrated up by 500 mg per week to a maximum of 2,000 mg per day.

ER metformin causes less GI distress than IR metformin in head-to-head trials. A 2017 meta-analysis (Aggarwal et al., Diabetes Therapy 2017) found roughly half the rate of treatment-limiting diarrhea in ER patients compared to IR. The trade-off: ER tablets cost slightly more, and the total daily ceiling is lower (2,000 mg vs 2,550 mg).

If your provider prescribes 2,000 mg ER and you still need more glucose lowering, the typical next step is a second medication, not a higher metformin dose. The kidney clearance of metformin is the main reason the ER ceiling stops at 2,000 mg.

Do not crush, chew, or split ER tablets. The empty tablet shell often appears in stool, which is normal and does not mean the medication did not absorb.

Maximum daily dose: IR vs ER

The FDA-approved maximum daily doses for adults are:

• Immediate-release metformin: 2,550 mg per day, divided into two or three doses
• Extended-release metformin: 2,000 mg per day, taken once daily with dinner
• Metformin solution (oral liquid): 2,550 mg per day, dosed like IR

Doses above the maximum do not produce additional glycemic benefit and increase the risk of GI side effects and lactic acidosis. The flat dose-response above 1,500 to 2,000 mg per day is one of the more consistent findings in metformin pharmacology (Garber et al., Am J Med 1997).

In real-world prescribing, the median maintenance dose hovers around 1,500 to 2,000 mg per day for most patients with type 2 diabetes.

Dosing in pediatric patients

Metformin is FDA-approved for type 2 diabetes in children aged 10 and older. The dosing schedule is similar to adults but with a lower starting dose and lower ceiling.

• Starting dose: 500 mg once daily with the evening meal
• Titration: increase by 500 mg per week
• Maximum daily dose: 2,000 mg per day in pediatric patients (lower than the adult IR ceiling of 2,550 mg)
• ER form: approved in adolescents 17 and older; not approved below age 17

Glycemic outcomes in pediatric trials were similar to adult trials, with comparable GI tolerability profiles. The Today Study (Today Study Group, NEJM 2012) is the largest randomized trial in this population and supports current pediatric dosing.

Kidney function and dose adjustment

Metformin is cleared almost entirely by the kidneys. Patients with reduced kidney function need dose reductions or, at very low function, must stop metformin entirely. The 2016 FDA labeling update replaced the old creatinine-based cutoffs with eGFR-based ones (FDA Drug Safety Communication, 2016).

Acute kidney injury, severe dehydration, and IV iodinated contrast all temporarily worsen kidney function. Standard practice is to hold metformin for 48 hours around any procedure with IV contrast and to recheck kidney function before restarting. Sick-day rules: hold metformin if you are vomiting, severely dehydrated, or unable to keep fluids down.

Metformin dosing in PCOS, prediabetes, and off-label use

Metformin is FDA-approved for type 2 diabetes only. Off-label uses include polycystic ovary syndrome (PCOS), prediabetes, gestational diabetes, and weight management adjunct in patients with insulin resistance.

PCOS: typical dose is 1,500 to 2,000 mg per day, titrated the same way as in diabetes. Most randomized trials in PCOS used 1,500 mg per day (Lord et al., BMJ 2003). Effects on ovulation rates, menstrual regularity, and androgen levels appear at this dose.

Prediabetes: the Diabetes Prevention Program (DPP) used 850 mg twice daily (1,700 mg per day) and showed a 31% relative reduction in progression to type 2 diabetes over three years compared to placebo (DPP Research Group, NEJM 2002). The benefit was larger in patients under 60 and in those with BMI ≥ 35.

Weight management adjunct: doses of 1,500 to 2,000 mg per day are typical in this off-label setting. Average weight loss attributable to metformin alone is modest, around 2 to 3% of body weight over six months, less than what GLP-1 receptor agonists produce.

Metformin alongside GLP-1 medications

Many patients take metformin together with a GLP-1 receptor agonist like semaglutide or tirzepatide. The combination is well-studied and generally well-tolerated.

The two drugs work through different mechanisms (metformin reduces hepatic glucose output; GLP-1 receptor agonists slow gastric emptying and enhance insulin secretion), so they stack rather than overlap. Combination therapy in trials produced larger A1C reductions than either drug alone (Pratley et al., Lancet Diabetes Endocrinol 2014).

Both drugs cause GI side effects, particularly nausea and diarrhea, so titration coordination matters. A common approach is to keep metformin at the patient's stable dose and titrate the GLP-1 medication slowly. If side effects compound, the GLP-1 dose, not the metformin dose, is usually held back, since GLP-1 agonists deliver larger weight-loss effects per dose increase.

For more on this combination, see our piece on GLP-1 medications and metformin together.

Missed doses and overdose

Missed dose: take it as soon as you remember, unless it is within a few hours of your next dose. Don't double up. Skipping a single dose has minimal effect on glucose control over the day.

Overdose: metformin overdose can cause lactic acidosis, a rare but serious complication. Symptoms include muscle pain, difficulty breathing, severe fatigue, abdominal discomfort, and irregular heartbeat. The risk is highest in patients with kidney impairment, dehydration, or alcohol use. If you have taken substantially more than your prescribed dose, contact poison control (1-800-222-1222 in the U.S.) or go to an emergency department.

The lethal dose in healthy adults is high. Most overdoses involve gram-quantity ingestions (10 grams or more). Small over-doses (one extra tablet) generally do not require emergency care unless GI symptoms are severe.

FAQ

What is the normal dose of metformin?

The typical maintenance dose for adults with type 2 diabetes is 1,500 to 2,000 mg per day, taken in two or three divided doses with food. Most patients start at 500 mg once or twice daily and titrate up by 500 mg per week.

Can I take 1,000 mg of metformin twice a day?

Yes. 1,000 mg twice daily (2,000 mg total) is one of the most common maintenance regimens for type 2 diabetes. It sits below the 2,550 mg ceiling for IR and matches the 2,000 mg ceiling for ER.

What is the maximum daily dose of metformin?

2,550 mg per day for immediate-release metformin and 2,000 mg per day for extended-release. Doses above these limits produce no additional glycemic benefit and raise the risk of GI side effects and lactic acidosis.

How long does it take metformin to work?

Metformin lowers fasting glucose within a few days, but full A1C effect takes 8 to 12 weeks. Don't judge effectiveness from the first month, especially if you're still titrating.

Should I take metformin in the morning or at night?

IR metformin is split between morning and evening meals. ER metformin is taken once with the evening meal. Evening dosing for ER reduces overnight liver glucose output, which is the main driver of fasting hyperglycemia.

Can I take metformin without food?

You can, but you'll have more GI side effects. Always take with the largest meal you can.

What happens if I miss a dose?

Take it when you remember, unless it's close to your next scheduled dose. Don't double up. One missed dose has minimal effect on glucose.

Is 500 mg of metformin enough?

For some patients, yes. Patients with mild type 2 diabetes or those using metformin for PCOS sometimes do well at 500 to 1,000 mg per day. The optimal dose is the lowest one that achieves your A1C target.

What if metformin makes me sick?

Try the ER form, which causes less GI distress. Make sure you're taking it with food. Slow the titration if you went up too quickly. If symptoms persist after a month at a stable dose, talk to your provider about alternatives.

Can I drink alcohol on metformin?

Light to moderate drinking is generally fine. Heavy or binge drinking raises the risk of lactic acidosis, which is the most serious metformin complication. The FDA labeling specifically warns against excessive alcohol use.

Does metformin cause weight loss?

Modestly. Most patients lose 2 to 3% of body weight over six months. It is not a primary weight-loss medication. GLP-1 medications produce far larger weight loss in head-to-head trials.

Can I stop metformin once my blood sugar is normal?

Talk to your provider before stopping. Some patients with prediabetes who reach normal glucose can taper off; most patients with type 2 diabetes need to stay on it long-term to keep glucose in range.

Related guides

• Maximum Dosage of Metformin Per Day: FDA Limits, Extended-Release vs. Immediate-Release, and When Higher Doses Backfire
• What Is Maximum Dosage of Metformin? FDA Limits, Off-Label Use, and When Higher Doses Fail
• What Is the Maximum Safe Metformin Dosage? FDA Limits, Titration Protocols, and When to Stop Increasing
• What Is the Maximum Daily Dose of Metformin? FDA Limits, Safety Thresholds, and When Higher Doses Stop Working
• What Is the Correct Semiglutide Dosage? A Complete Titration Guide from Starting Dose to Maximum
• Metformin Maximum Dosage Per Day: FDA Limits, Extended-Release Differences, and When Higher Isn't Better
• Tool: dosage calculator

Sources

1. American Diabetes Association. Standards of Care in Diabetes. Diabetes Care. 2024;47(Suppl 1).
2. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
3. Aggarwal N, et al. Comparative tolerability of immediate-release and extended-release metformin: a meta-analysis. Diabetes Therapy. 2017;8:347-359.
4. Garber AJ, et al. Efficacy of metformin in type 2 diabetes: dose-response analysis. American Journal of Medicine. 1997;103:491-497.
5. FDA Drug Safety Communication. Revised warnings for use of metformin in certain patients with reduced kidney function. April 2016.
6. Today Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. New England Journal of Medicine. 2012;366:2247-2256.
7. Lord JM, et al. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003;327:951.
8. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002;346:393-403.
9. Pratley R, et al. Once-weekly semaglutide versus exenatide ER in patients with type 2 diabetes. Lancet Diabetes & Endocrinology. 2014.
10. U.S. National Library of Medicine. Metformin hydrochloride prescribing information. DailyMed, accessed 2026.
11. Inzucchi SE, et al. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA. 2014;312:2668-2675.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Metformin brand names (Glucophage, Glumetza, Fortamet, Riomet) are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.